Sales were \u00a56,247 million, up 4.3% YoY. Operating profit was \u00a517 million (down 67.4% YoY), ordinary profit was \u00a522 million (down 57.0% YoY), net income attributable to owners of the parent was \u00a523 million (down 49.7% YoY). For FY2027 full-year, sales are forecast at \u00a525,200 million, operating profit \u00a5600 million, net income attributable to owners of the parent \u00a5360 million. Increases\/decreases by segment: Pharmaceuticals, Childcare Support, Nursing Care, and Food. Self-owned capital ratio improved to 29.5%. Supplemental quarterly results materials available; earnings briefing to be held.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7129","jir_company_name":"Mia Halsa Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/7129-20260810-01.pdf","jir_short_summary":"Sales were \u00a56,247 million, up 4.3% YoY. Operating profit was \u00a517 million (down 67.4% YoY), ordinary profit was \u00a522 million (down 57.0% YoY), net income attributable to owners of the parent was \u00a523 million (down 49.7% YoY). For FY2027 full-year, sales are forecast at \u00a525,200 million, operating profit \u00a5600 million, net income attributable to owners of the parent \u00a5360 million. Increases\/decreases by segment: Pharmaceuticals, Childcare Support, Nursing Care, and Food. Self-owned capital ratio improved to 29.5%. Supplemental quarterly results materials available; earnings briefing to be held.","jir_summary":"### Overview of performance\nWhile first-quarter sales increased, operating profit, ordinary profit, and net income fell below the previous year due to drug price revisions, revision of dispensing rewards, and higher personnel costs. In the Pharmaceuticals segment, prescriptions increased and unit prices rose, contributing to sales, but restraints on drug prices and technical fees affected profitability. The childcare support segment posted higher revenue and profit due to contributions from new facilities and official price increases in supplementary budgets. The nursing care segment saw stable occupancy but worsened profitability. Total assets and liabilities declined, and the equity ratio improved to 29.5%. The full-year forecast remains unchanged from the prior announcement.\n\n### Outlook and impact for investors\nToward the final year of the mid-term plan, FY2027, strengthen the rollout of child-rearing and elderly support under national welfare policies. Aim to create synergy between segments and improve operating margin. The earnings summary does not indicate revisions, so the current full-year outlook is maintained. Expansion of childcare facilities and profitability improvements in nursing care are key. Financial soundness is improving, with rising equity ratio suggesting stability.","jir_financial_highlights":"Sales: 6,247\u767e\u4e07\u5186 (\u524d\u5e74\u540c\u671f\u6bd44.3\uff05\u5897)\nOperating profit: 17\u767e\u4e07\u5186 (\u524d\u5e74\u540c\u671f\u6bd4\u25b367.4\uff05\u6e1b)\nOrdinary profit: 22\u767e\u4e07\u5186 (\u524d\u5e74\u540c\u671f\u6bd4\u25b357.0\uff05\u6e1b)\nNet income attributable to owners of the parent (quarter): 23\u767e\u4e07\u5186 (\u524d\u5e74\u540c\u671f\u6bd4\u25b349.7\uff05\u6e1b)\nFull-year sales forecast: 25,200\u767e\u4e07\u5186 (\u5909\u66f4\u306a\u3057)\nEquity ratio: 29.5\uff05 (\u524d\u671f\u6bd4+4.4\u30dd\u30a4\u30f3\u30c8)","jir_category":"","jir_hashtags":"#MiaHalsaHoldings, #FinancialSummary, #Segment, #MidTermPlan","jir_key_figures":"Sales: 6,247\u767e\u4e07\u5186 (\u524d\u5e74\u540c\u671f\u6bd44.3\uff05\u5897)\nOperating profit: 17\u767e\u4e07\u5186 (\u524d\u5e74\u540c\u671f\u6bd4\u25b367.4\uff05\u6e1b)\nNet income attributable to owners of the parent (quarter): 23\u767e\u4e07\u5186 (\u524d\u5e74\u540c\u671f\u6bd4\u25b349.7\uff05\u6e1b)","jir_meta_title":"\u3010Mia Halsa Holdings\u3011Q1 FY2027 Financial Summary, Sales Up but Profit Down | FY2027","jir_meta_description":"Mia Halsa Holdings' Q1 FY2027 results show sales exceeding the previous year, but profits decline due to drug price revisions and other factors. This document summarizes segment trends and full-year prospects for investors.","jir_og_title":"Mia Halsa HD Q1 Results | Sales Up, Profit Down","jir_og_description":"Mia Halsa HD Q1 results. Sales of \u00a56,247 million, operating profit of \u00a517 million, net income of \u00a523 million. Full-year forecast maintained; key segment trends and financial status summarized.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60671,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-101560","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n